Ericsson: Barclays downgrades to ‘underweight’

Gecina in the red: Morgan Stanley downgrades

Safran: Bernstein downgrades his opinion

AstraZeneca: Jefferies downgrades to ‘keep’

Kering: an analyst downgrades

Bayer: Deutsche Bank downgrades to ‘hold’